Plant-Based Vaccine Manufacturing for Influenza, Implications for Future Vaccines
An emerging body of research highlights plant-based vaccine manufacturing as a potential solution to risks posed by traditional egg-based manufacturing.
Diagnosis & Disease Information
Guidance Issued for COVID-19 Vaccination of Cancer Patients
Patients with cancer should be prioritized for vaccination; caregivers and household/close contacts should undergo vaccination when possible
Herd Immunity 101: Explaining Vaccination Effectiveness to Patients
Detailing the importance of immunization and clarifying the concept of herd immunity to patients is a worthwhile conversation at any time but especially relevant in the COVID-19 era, rife with an abundance of information and misinformation. A good way to approach the subject is to change the terminology. “Herd immunity originally applied to farm animals,”…
Immunization Schedules: Best Available Evidence for 2020
Review of the Advisory Committee Immunization Practices updates to the pediatric immunization schedule and significant revisions to the adult immunization schedule.
Moderna Charging Much More for COVID-19 Vaccine Than Others
Moderna is charging $37 a dose for its experimental vaccine, which is far more than what other companies say they plan to charge for their vaccines.
Plenty of COVID-19 Vaccine Coming, Fauci Says
When a COVID-19 vaccine is approved, there should be plenty of it available.
Early Data Show Investigational ChAdOx1 nCoV-19 Vaccine Safe, Immunogenic
Interim results from the phase 1/2 COV001 trial evaluating the vaccine candidate ChAdOx1 nCoV-19 (AZD1222) showed that vaccination led to strong immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in all evaluated participants.
COVID-19 Vaccine Initiative May Favor Rich Countries
A global COVID-19 vaccine initiative has been formed with the objective of ensuring fair distribution of vaccines worldwide, but it may benefit rich countries more than poor nations.
Immune Responses Observed in All Participants Dosed With Moderna’s COVID-19 Vaccine Candidate
Participants demonstrated high levels of neutralizing antibody activity that exceeded those seen in convalescent sera obtained from persons with confirmed COVID-19.
Model Estimates Herd Immunity Threshold for COVID-19
A mathematical model shows that SARS-CoV-2 disease-induced herd immunity level may be lower than the classical model assuming homogenous immunization.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...